Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
HCA · against 1,336 other Healthcare companies
Ranked #235 of 1,337 · scores higher than 82% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 80–89, including HCA · Click a bar to see the companies
Mainly thanks to its earnings yield, free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | HCA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 6.4% | 1.5% | 86% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 10.2% | 4.2% | 81% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 6.0% | -1.0% | 84% | 20% | |
| Book yieldHigher is better · 1,306 reported | -6.6% | 37.9% | 3% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 235 | 3.5B USD | 82 | 75 | |
| 235 | 838M EUR (≈$922M) | 82 | 71 | |
| 235 | 439M EUR (≈$482M) | 82 | 46 | |
| 235 | 162.93T ARS (≈$162.9B) | 82 | 63 | |
| 235 | 100.2B USD | 82 | 57 | |
| 235 | 131M CAD (≈$96M) | 82 | 40 | |
| 235 | 23.8B USD | 82 | 84 | |
| 235 | 1.6B NZD (≈$946M) | 82 | 52 | |
| 249 | 20.7B CNY (≈$2.9B) | 81 | 51 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score